Full-Time

QA Document Control Lead

Confirmed live in the last 24 hours

Legend Biotech

Legend Biotech

1,001-5,000 employees

Develops and commercializes cell therapies

Biotechnology
Healthcare

Senior

Bridgewater Township, NJ, USA

Category
QA & Testing
Manual Testing
Quality Assurance
Requirements
  • A minimum of 6 years relevant work experience is required. It is preferable that the candidate have experience working in an aseptic manufacturing facility, preferably in quality assurance, manufacturing compliance, clinical quality, or cell therapy.
  • A minimum of a Bachelor’s Degree in Science, Information Science or equivalent is required.
Responsibilities
  • Day to day management of resources, planning and assigning work to Document Control Specialists to meet goals and deadlines.
  • Serve as a Document Control reviewer for new and revised procedures and documents to ensure compliance with global and site procedures as needed.
  • Ability to manage multiple and complex projects, provide status reports, and coordinate with cross-functional departments.
  • Support Document Management system users with workflow handling and electronic system usage, as needed.
  • Manage the periodic review process for procedures, as needed.
  • Issue batch related documentation and labels in support of GMP manufacturing.
  • Reconcile GMP documentation following document lifecycle requirements.
  • Create and issue GMP logbooks.
  • Responsible for storage and archival of GMP documents and batch related records.
  • Perform tasks in a manner consistent with the safety policies, quality systems and cGMP requirements.
  • Drive continuous improvement.
  • Have advanced computer skills to increase department’s productivity, as well as broadening technical and scientific knowledge.

Legend Biotech develops and commercializes cell therapies aimed at treating serious diseases, particularly cancers like hematological malignancies and solid tumors. Their approach is technology agnostic, allowing them to explore various methods to find effective treatments. The company operates in the personalized medicine sector, focusing on discovering, developing, and bringing new therapies to market. They generate revenue through licensing and selling their therapies, including CAR-T therapies, which involve modifying a patient's cells to combat cancer. Legend Biotech emphasizes transparency with investors, regularly updating them on financial results and business developments.

Company Stage

IPO

Total Funding

$146.4M

Headquarters

Franklin Township, New Jersey

Founded

2014

Growth & Insights
Headcount

6 month growth

0%

1 year growth

-1%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • Recent FDA and European approvals for CARVYKTI® expand its market reach in multiple myeloma.
  • New R&D facility in Philadelphia boosts innovation in next-generation cell therapies.
  • Alan Bash's appointment could accelerate CARVYKTI®'s growth and market penetration.

What critics are saying

  • Increased competition from Amgen's Imdelltra may impact CAR-T therapy focus.
  • Collaboration with Multiply Labs may face technological challenges, delaying production timelines.
  • Financial strain from new R&D facility could affect operational focus if advancements lag.

What makes Legend Biotech unique

  • Legend Biotech focuses on novel cell therapies for oncology, including CAR-T and NK cells.
  • The company is technology agnostic, exploring multiple platforms for effective cancer treatments.
  • Legend Biotech's CARVYKTI® is the first BCMA-targeted CAR-T therapy approved for second-line use.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Paid Sick Leave

Paid Holidays

Remote Work Options